How did the once functionary role of Chief Compliance Officer become so important? Read on for a fast history and definition of the CCO, role and also a look at where this evolving position may be going.
Michael Verde of Katten Muchin Rosenman explains the characteristics that create a superior CCO who has the ability to balance between what often seem like diametrically opposed values and goals.
Thomas Fox discusses the ongoing debate in the compliance arena as to whom a Chief Compliance Officer (CCO) should report. There are a variety of setups, but is one approach more right or wrong than another?
For years in some heavily regulated industries the Chief Compliance Officer role is seen by the board and the company’s shareholders to be “table stakes.” As Chris DePippo of CSC explains, in these industries, the Chief Compliance Officer may be the most important figure aside from the CEO.
Curtis Schehr was fired by DynCorp International, reports August Cole of the Wall Street Journal. According to Cole, Schehr, who had been DynCorp’s Chief Compliance Officer and Executive Counsel, as well as a Senior V.P., was fired “without cause”.
Walgreens recently announced two significant compliance-related personnel decisions. Laura K. Merten, who had been serving as the company’s divisional VP of health law, has now been appointed Chief Compliance Officer as well as divisional VP of compliance, loss prevention, and profit sharing.
Brewer Investment Group, an independent wealth management firm, today announced the appointment of Mr. William R. Turner as Chief Compliance Officer and Mr. Matthew L. Lovett as Compliance Principal for two of Brewer’s fastest growing divisions, Brewer Financial Services and Brewer Investment Advisors.
New featured article by Luis Ramos, Chief Executive Officer for The Network. As with many situations of adversity, the current economic downturn presents an opportunity for a Chief Compliance Officer (CCO) to strengthen their company’s ethics and compliance programs.
Howard Bernstein, formerly with Wedbush Securities, has been named the Chief Compliance Officer at Merriman Curhan Ford, a financial services firm focused on “fast-growing companies and the institutions that invest in them.”
As part of its settlement with the DOJ, Pfizer must now adhere to a corporate integrity agreement that dictates its General Counsel can longer operate as the head of compliance.
